Skip to main content
. 2021 Feb 14;51(3):595–607. doi: 10.1007/s11239-021-02394-7

Table 2.

Incidence of thrombotic complications in the whole cohort and in patients with and without routine ultrasound screening for deep venous thrombosis

Type of thrombosis Incidence of thrombotic complication in total patient cohort (n = 2929) Incidence of event in patients not routinely screened for DVT Incidence of event in patients routinely screened for DVT Comparison of the incidence of thrombosis with screening vs. without screening
DVT 431/2671 (16.1%) 256/2328 (11.0%) 151/268 (56.3%) 56.3% vs. 11.0% (p < 0.001)
PE 325/2580 (12.6%) 277/2298 (12.1%) 37/207 (17.9%) 17.9% vs. 12.6% (p = 0.009)
CVA 52/1736 (3.0%) 52/1736 (3.0%) NA NA
MI 137/1736 (8.0%) 137/1736 (8.0%) NA NA
Line thrombosis 13/574 (2.3%) 13/574 (2.3%) NA NA
Limb or Mesenteric ischaemia 39/1566 (2.5%) 39/1566 (2.5%) NA NA
Oxygenator thrombosis (ECMO) 13/48 (27.1%) 13/48 (27.1%) NA NA
Circuit thrombosis (RRT) 28/29 (96.6%) 28/29 (96.6%) NA NA

CVA cerebrovascular accident, DVT deep venous thrombosis, ECMO extracorporeal membrane oxygenation, MI myocardial infarction, NA not available, PE pulmonary embolism, RRT renal replacement therapy